-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BCR-ABL Tests Market Report Overview The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests...
-
Product Insights
Asuragen Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Asuragen Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that offers laboratory medicine solutions. The company's products include amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It...
-
Report Bundle
56% offTrends in Medical Devices – Report Bundle (7 Reports)
A rise in disease awareness, improved accessibility to personalized medicine, and technological advancements are transforming the medical device industry. It is helping patients to avoid potential adverse events and reducing unnecessary hospitalizations and outpatient costs. The field has expanded from a handful of drug manufacturers to include many high-end manufacturers. Accessing the in-depth insight from the Trends in Medical Devices bundle can help you: Make informed decisions about investments, partnerships, and product development Understand your competitors’ strengths and weaknesses, identify areas...
-
Thematic Analysis
Companion Diagnostics – Thematic Research
Companion diagnostics (CDx) are molecular assays that measure levels of proteins, genes, or specific mutations to reveal a specific, efficacious therapy for an individual’s condition. CDx are a form of personalized, stratified, and precision medicine due to which a patient’s treatment will become increasingly individualized. CDx has expanded from a handful of oncology drugs with corresponding diagnostics to include multiple therapeutic areas, and the number of combinations has grown significantly over the years. However, oncology remains the largest segment for...
-
Product Insights
Prenatal Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Prenatal Screening Tests includes the sub-segments Free Beta Human Chorionic Gonadotropin (hCG) Tests, Pregnancy Associated Plasma Protein A (PAPP-A) Tests, Total Human Chorionic Gonadotropin (hCG) Tests, Unconjugated Estriol (uE3) Tests, Alpha-Fetoprotein (AFP) Tests and Inhibin A Tests. GlobalData's Medical Devices sector report, “Prenatal Screening Tests - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Prenatal Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Sector Analysis
Canada Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery
GlobalData’s “Canada Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Canada Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Glucose Monitoring and Insulin Delivery. The Canada Diabetes Care Devices Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...